Table 1 Baseline characteristics of the study population (n = 172)
Characteristic | |
|---|---|
Women, no./total (%) | 139/172 (80.8) |
Age, mean ± SD, years | 49.5 ± 12.8 |
Smoking status, no. (%) | |
Current smoking | 46 (26.7) |
Past smoking | 42 (24.4) |
Never smoked | 93 (54.1) |
DAS28, no. (%) | |
Low disease activity | 1 (0.6) |
Moderate disease activity | 70 (40.7) |
High disease activity | 101 (58.7) |
Tender joint count, mean ± SD | 9 ± 5.5 |
Swollen joint count, mean ± SD | 11.7 ± 7.1 |
HAQ-DI, mean ± SD | 1.1 ± 0.7 |
ESR (mm/h), mean ± SD | 25.2 ± 23.6 |
CRP (mg/dl), mean ± SD | 23.2 ± 42.8 |
mTSS, mean ± SD | 5.5 ± 7.0 |
Treatment, no. (%) | |
Methotrexate | 98 (57) |
Leflunomide | 12 (7) |
Sulfasalazine | 22 (12.8) |
Hydroxychloroquine | 37 (21.5) |
Cyclophosphamide | 1 (0.6) |
Biologic DMARD | 2 (1.2) |